Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Anderson

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
JCO Oncology Practice|May 9, 2020
Food Insecurity and Forgone Medical Care Among Cancer SurvivorsJean A McDougall, Jessica Anderson, Shoshana Adler Jaffe, et al.
Science Translational Medicine|July 21, 2012
Continuous intravesical lidocaine treatment for interstitial cystitis/bladder pain syndrome: safety and efficacy of a new drug delivery deviceJ Curtis Nickel, Pankaj Jain, Neal Shore, et al.
Cancer|February 4, 2005
Bortezomib in recurrent and/or refractory multiple myeloma. Initial clinical experience in patients with impared renal functionSundar Jagannath, Bart Barlogie, James R Berenson, et al.
BMC Cancer|April 14, 2021
Analytical validation of the Percepta genomic sequencing classifier; an RNA next generation sequencing assay for the assessment of Lung Cancer risk of suspicious pulmonary nodulesMarla K Johnson, Shuyang Wu, Daniel G Pankratz, et al.
Journal of Midwifery & Women'S Health|April 9, 2026
Outcomes for Labor Induction Compared With Expectant Management Among Women Receiving Hospital-Based, Midwifery-Led CareDenise Colter Smith, Jena Wallander Gemkow, Bethelhem A Shiferaw, et al.
Journal of Extracellular Biology|August 18, 2025
Oral Bioavailability of a Noncoding RNA Drug, TY1, That Acts on MacrophagesShukuro Yamaguchi, Kazutaka Miyamoto, Xaviar M Jones, et al.
Drug and Alcohol Dependence|February 14, 2026
Achieving SVR is associated with long term reduced hazardous alcohol use for people who inject drugs receiving HCV treatment: The HERO studyEmily Waters, Jessica Obeysekare, Snehal Lopes, et al.
Journal of Hepatology|January 19, 2024
Optimal hepatitis C treatment adherence patterns and sustained virologic response among people who inject drugs: The HERO studyMoonseong Heo, Brianna L Norton, Irene Pericot-Valverde, et al.
Viruses|October 26, 2024
Variability of Hepatitis C Treatment Cascade Outcomes among People Who Inject Drugs across Geographically Diverse Clinics in the US: The HERO StudySnehal S Lopes, Moonseong Heo, Irene Pericot-Valverde, et al.
The International Journal on Drug Policy|December 16, 2023
Self-reported and measured adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs: The HERO studySnehal S Lopes, Irene Pericot-Valverde, Julia Arnsten, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
JCO Oncology Practice|May 9, 2020
Food Insecurity and Forgone Medical Care Among Cancer SurvivorsJean A McDougall, Jessica Anderson, Shoshana Adler Jaffe, et al.
Science Translational Medicine|July 21, 2012
Continuous intravesical lidocaine treatment for interstitial cystitis/bladder pain syndrome: safety and efficacy of a new drug delivery deviceJ Curtis Nickel, Pankaj Jain, Neal Shore, et al.
Cancer|February 4, 2005
Bortezomib in recurrent and/or refractory multiple myeloma. Initial clinical experience in patients with impared renal functionSundar Jagannath, Bart Barlogie, James R Berenson, et al.
BMC Cancer|April 14, 2021
Analytical validation of the Percepta genomic sequencing classifier; an RNA next generation sequencing assay for the assessment of Lung Cancer risk of suspicious pulmonary nodulesMarla K Johnson, Shuyang Wu, Daniel G Pankratz, et al.
Journal of Midwifery & Women'S Health|April 9, 2026
Outcomes for Labor Induction Compared With Expectant Management Among Women Receiving Hospital-Based, Midwifery-Led CareDenise Colter Smith, Jena Wallander Gemkow, Bethelhem A Shiferaw, et al.
Journal of Extracellular Biology|August 18, 2025
Oral Bioavailability of a Noncoding RNA Drug, TY1, That Acts on MacrophagesShukuro Yamaguchi, Kazutaka Miyamoto, Xaviar M Jones, et al.
Drug and Alcohol Dependence|February 14, 2026
Achieving SVR is associated with long term reduced hazardous alcohol use for people who inject drugs receiving HCV treatment: The HERO studyEmily Waters, Jessica Obeysekare, Snehal Lopes, et al.
Journal of Hepatology|January 19, 2024
Optimal hepatitis C treatment adherence patterns and sustained virologic response among people who inject drugs: The HERO studyMoonseong Heo, Brianna L Norton, Irene Pericot-Valverde, et al.
Viruses|October 26, 2024
Variability of Hepatitis C Treatment Cascade Outcomes among People Who Inject Drugs across Geographically Diverse Clinics in the US: The HERO StudySnehal S Lopes, Moonseong Heo, Irene Pericot-Valverde, et al.
The International Journal on Drug Policy|December 16, 2023
Self-reported and measured adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs: The HERO studySnehal S Lopes, Irene Pericot-Valverde, Julia Arnsten, et al.
Pageof 8